Taj
Pharmaceuticals Limited firmly believes that quality can not
be talked into a product,
but has to exist inherently. Its efforts towards realizing
world-class quality standards.
Taj
Pharmaceuticals Limited’s rapid growth and expansion in the
international and domestic markets led to the commencement of
a new formulations manufacturing facility at Baddi, Himachal
Pradesh, in the last quarter of 2010-11. The upcoming
facility, built
to world-class standards, will have capacity to manufacture
2100 mn tablets and
shall become operational in JN 15.
Investment of
around 2.35 million USD is also being made to augment the API
capacity
in Taj Pharmaceuticals Limited’s existing plant at Maharashtra
.This will ensure supply of quality API for supply of
formulations to the regulated markets, especially USA and EU.
An
organisations’ capabilities and intent are strongly reflected
in the product it manufactures. In other words, the
manufacturing competencies and facilities echo truly, the R&D
extent and the ability to implement it for the best of the
market it targets.
Taj
Pharmaceuticals Limited’s manufacturing strengths have
established it as a producer of world-class generics, branded
generics and a major supplier of its range of Active
Pharmaceutical Ingredients. Taj Pharmaceuticals Limited has
world-class manufacturing facilities in seven countries namely
China, Ireland, India, Malaysia, Nigeria, USA and Vietnam. Its
overseas facilities are designed to cater to the requirements
of the local regulatory bodies of that country while the
Indian facilities meet the requirements of all International
Regulatory Agencies. Some of the agencies such as MCA-UK,
MCC-Sout Africa, FDA-USA and TGA-Australia, have audited and
approved Taj Pharmaceuticals Limited’s manufacturing
facilities for the compliance with international. Good
Manufacturing Practices and have registered its products for
safety, quality and efficacy. Taj Pharmaceuticals Limited
exports raw materials, intermediates, prescription drugs, OTC
products and veterinary products. Taj Pharmaceuticals Limited
also offers technology for products and processes. Technical
know-how/fees received during the year 2004-05 amounted to
Rs.415 million. Taj Pharmaceuticals Limited's manufacturing
facilities have been approved by the following regulatory
authorities: |
|